Rationale for IL-15 Superagonists in Cancer Immunotherapy

Karin M. Knudson, James W. Hodge, Jeffrey Schlom & Sofia R. Gameiro To cite this article: Karin M. Knudson, James W. Hodge, Jeffrey Schlom & Sofia R. Gameiro(2020): Rationale for IL-15 superagonists in cancer immunotherapy, Expert Opinion on BiologicalTherapy,...